Nektar Therapeutics (NKTR)
1.255
-0.06
(-4.92%)
USD |
NASDAQ |
Apr 19, 16:00
1.27
+0.02
(+1.20%)
After-Hours: 20:00
Nektar Therapeutics Total Return Price: 1.255 for April 19, 2024
Total Return Price Chart
Historical Total Return Price Data
Date | Value |
---|---|
April 18, 2024 | 1.32 |
April 17, 2024 | 1.35 |
April 16, 2024 | 1.49 |
April 15, 2024 | 1.57 |
April 12, 2024 | 1.67 |
April 11, 2024 | 1.58 |
April 10, 2024 | 1.29 |
April 09, 2024 | 1.25 |
April 08, 2024 | 1.31 |
April 05, 2024 | 1.32 |
April 04, 2024 | 1.32 |
April 03, 2024 | 1.04 |
April 02, 2024 | 0.95 |
April 01, 2024 | 0.9041 |
March 28, 2024 | 0.9342 |
March 27, 2024 | 0.8851 |
March 26, 2024 | 0.90 |
March 25, 2024 | 0.8881 |
March 22, 2024 | 0.9135 |
March 21, 2024 | 0.8973 |
March 20, 2024 | 0.90 |
March 19, 2024 | 0.8682 |
March 18, 2024 | 0.85 |
March 15, 2024 | 0.8602 |
March 14, 2024 | 0.86 |
Date | Value |
---|---|
March 13, 2024 | 0.85 |
March 12, 2024 | 0.89 |
March 11, 2024 | 0.8317 |
March 08, 2024 | 0.9091 |
March 07, 2024 | 0.9556 |
March 06, 2024 | 0.9099 |
March 05, 2024 | 0.8841 |
March 04, 2024 | 0.90 |
March 01, 2024 | 0.78 |
February 29, 2024 | 0.71 |
February 28, 2024 | 0.72 |
February 27, 2024 | 0.75 |
February 26, 2024 | 0.67 |
February 23, 2024 | 0.6824 |
February 22, 2024 | 0.661 |
February 21, 2024 | 0.69 |
February 20, 2024 | 0.6636 |
February 16, 2024 | 0.7119 |
February 15, 2024 | 0.74 |
February 14, 2024 | 0.77 |
February 13, 2024 | 0.655 |
February 12, 2024 | 0.712 |
February 09, 2024 | 0.71 |
February 08, 2024 | 0.685 |
February 07, 2024 | 0.67 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
0.4227
Minimum
Nov 28 2023
36.27
Maximum
Jul 03 2019
12.29
Average
15.37
Median
Dec 21 2021
Total Return Price Benchmarks
Stereotaxis Inc | 2.50 |
Vanda Pharmaceuticals Inc | 5.115 |
Cara Therapeutics Inc | 0.689 |
Marinus Pharmaceuticals Inc | 1.375 |
DiaMedica Therapeutics Inc | 2.40 |